The BioHub - by Avetix

Episode 253 - John Yu CEO at Kairos Pharma

In this episode of The BioHub Podcast, Ben is joined by Dr. John Yu, CEO and Chairman of Kairos Pharma, a clinical-stage biotechnology company developing innovative thera

Episode 252 - Sam Reich - CEO at SAB Bio

In this episode of The BioHub by Avetix, I’m joined by Sam Reich, CEO of SAB BIO. Sam shares his unconventional journey from leaving his PhD to build his first biotech,

Episode 250 - Dr. Garry Pairaudeau, Co-Founder CEO & Dr. Anthony Bradley, Co-Founder CSO of Dalton Tx

In this episode of The BioHub, Amber is joined by Dr. Garry Pairaudeau, Co-Founder and CEO, and Dr. Anthony Bradley, Co-Founder and CSO of Dalton Tx. Having previously w

Why Biotech Keeps Reinventing the Wheel | Greg Crescenzi, Addgene

Why spend months recreating research tools that another lab has already built? In this episode of The BioHub, we’re joined by Greg Crescenzi from Addgene to discuss how

Episode 248- Marshall Fordyce - Founder & CEO of Vera Therapeutics

In this episode of The BioHub by Avetix, I’m joined by Marshall Fordyce, Founder and CEO of Vera Therapeutics. Marshall shares his journey from medicine and HIV drug dev

Episode 247 - Chris Moxham Founder & CEO and Clayton Mellina CTO of Transcripta Bio

In this episode of The BioHub, Amber is joined by Dr. Chris Moxham, Co-founder and CEO of Transcripta Bio, and Clayton Mellina, CTO, to explore how transcriptomics and AI

Episode 246 - Neil Warma - CEO, ProMIS Neurosciences

In this episode of The BioHub Podcast by Avetix, we welcome Neil Warma, President and CEO of ProMIS Neurosciences, a clinical-stage biotechnology company developing next-

Episode 245 - Michael Fenn CBO Bexorg

On this episode of The BioHub, Amber Hayes is joined by Michael Fenn, Chief Business Officer at Bexorg, a precision neurology company combining AI with a pioneering whole

Episode 244 - Erik Wiklund & Thomas Hansen - CEO & CTO of Circio

On this episode, we sit down with the CEO & CTO of Circio to get into the world of circular RNA. Erik, Thomas and the team are developing circVec, a circular RNA express

Episode 243 - Johanna Kaufman: CSO at DeckBio

We were delighted to be joined by Johanna Kaufmann, Chief Scientific Officer at Deck Bio. Johanna has spent her career at the intersection of oncology, immunology and dr

Episode 242 - Sam Blackman

We were delighted to be joined by Dr. Sam Blackman, a physician-scientist, biotech entrepreneur and investor who has built a fascinating career across medicine, drug deve

Episode 241 - Howard Berman & Kia Motesharei - ReAlta Life Sciences

We were delighted to be joined by two highly experienced leaders in the biotechnology industry, Howard Berman, Ph.D., and Kia Motesharei, Ph.D. Both Howard and Kia have

Episode 240 - Inder Kaul - CMO at Draig Therapeutics

In this episode of The BioHub Podcast, Ben sits down with Dr. Inder Kaul, Chief Medical Officer at Draig Therapeutics, to discuss the evolution of neuropsychiatric drug d

Episode 239 - Eran Seger - CEO & Co-Founder Protai

In this episode of The BioHub by Avetix, I’m joined by Eran Seger, CEO and Co-Founder of Protai. Eran shares his unique journey into biotech and the inspiration behind f

Episode 238 - Mandana Honu Fathom Therapeutics

We welcomed Mandana Honu onto the BioHub podcast

Episode 237 - Marc Hedrick & Russell Bradley- Cerenome

In this episode of The BioHub Podcast, Ben is joined by Dr. Marc Hedrick, President & CEO of Cerenome, and Russell Bradley, President & General Manager of CNSide Diagnost

Episode 236 - Dan O’Connell - President & CEO of Acumen Pharmaceuticals

In this episode of The BioHub by Avetix, I’m joined by Dan O’Connell, President and CEO of Acumen Pharmaceuticals. Dan shares his journey from neuroscience investing and

Episode 235 - Paul Hastings - CEO NKarta

In this episode of The BioHub by Avetix, I’m joined by Paul Hastings, CEO of Nkarta. Paul has spent more than three decades in biotech, leading companies across oncology

Epsiode 234 - Lei Fang CEO Excalipoint

We welcomed Lei Fang the CEO of Excalipoint to the BioHub

Episode 233 - Jay Fine - President R&D at Evolveimmune Therapeutics

Today we’re joined by Jay Fine, President of Research & Development at EvolveImmune Therapeutics. Jay has spent more than 30 years working across drug discovery and deve